HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.
Why Hologic ( HOLX ) Outpaced the Stock Market Today
In the closing of the recent trading day, Hologic (HOLX) stood at $67.91, denoting a +1.3% move from the preceding trading day.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HOLX vs. IDXX: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic ( HOLX Quick QuoteHOLX - ) and Idexx Laboratories ( IDXX Quick QuoteIDXX - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum
HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.
Why Hologic ( HOLX ) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test
QDEL boosts its respiratory testing lineup with the FDA-cleared QUICKVUE Influenza + SARS Test for professional use.
Hologic, Inc. ( HOLX ) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Volition Signs Co-Marketing and Services Agreement with Hologic - Hologic ( NASDAQ:HOLX ) , VolitionRX ( AMEX:VNRX )
HENDERSON, Nev., Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited ( NYSE: VNRX ) ( "Volition" ) , a multi-national epigenetics company, today announces that it has signed an agreement with Hologic Diagenode ( "Hologic" ) for the co-marketing of Volition's Nu.Q® Discover service.
Why Hologic ( HOLX ) Outpaced the Stock Market Today
Hologic (HOLX) closed at $67.21 in the latest trading session, marking a +2.16% move from the prior day.
HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?
Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.
HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?
Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.
908 Devices ( MASS ) Surges 7.0%: Is This an Indication of Further Gains?
908 Devices (MASS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Hologic ( HOLX ) Stock Falls Amid Market Uptick: What Investors Need to Know
Hologic (HOLX) concluded the recent trading session at $66.33, signifying a -2.84% move from its prior day's close.
Hologic, Inc. ( HOLX ) Is a Trending Stock: Facts to Know Before Betting on It
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic's Strong International Traction to Continue Despite Headwinds
HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.
Hologic ( HOLX ) Soars 7.7%: Is Further Upside Left in the Stock?
Hologic (HOLX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Women's Health Collective Canada Launches Vital Talks National Seminar Series with the Support of Vichy Laboratoires
TORONTO, Sept. 15, 2025 ( GLOBE NEWSWIRE ) -- Women's Health Collective Canada ( WHCC ) is proud to announce the launch of Vital Talks, a new national online seminar series bringing together leading researchers, clinicians, and voices with lived experience to spotlight the science shaping better ...
Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?
HOLX's Breast Health revival, fueled by AI, leadership shifts and product upgrades, is setting up a growth rebound.
Hologic ( HOLX ) Stock Sinks As Market Gains: What You Should Know
The latest trading day saw Hologic (HOLX) settling at $65.51, representing a -1.82% change from its previous close.
Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds
HOLX lifts its 2025 revenue and EPS outlook on Q3 strength, tariff relief, and growth across Breast Health and GYN Surgical.
Investors Heavily Search Hologic, Inc. ( HOLX ) : Here is What You Need to Know
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic's Panther Fusion Signals More Molecular Diagnostics Upside
HOLX's Panther Fusion expands its diagnostics menu, fueling assay growth and unlocking more upside in molecular testing.
Hologic ( HOLX ) Down 0.3% Since Last Earnings Report: Can It Rebound?
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?
HOLX fuels growth with targeted M&A across Diagnostics, Breast Health, and GYN Surgical, backed by a strong balance sheet.
Here is What to Know Beyond Why Hologic, Inc. ( HOLX ) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?
Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Hologic ( HOLX ) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?
HOLX's Genius digital cytology system and global rollout position its Cytology unit for long-term growth despite near-term headwinds.
Is Trending Stock Hologic, Inc. ( HOLX ) a Buy Now?
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength
HOLX targets a mid-single-digit organic growth rebound in 2026, powered by Breast Health recovery and new product innovation.
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?
HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.
Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings?
HOLX rises post earnings beat, fueled by Diagnostics strength and Surgical growth. However, macro headwinds persist.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tempus AI Targets Breast Cancer With Expanded Next - AI Platform
TEM expands its AI-driven Tempus Next platform into breast cancer, targeting key testing gaps to improve care delivery.
Why Hologic ( HOLX ) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Interpreting Hologic ( HOLX ) International Revenue Trends
Evaluate Hologic's (HOLX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Hologic, Inc. ( HOLX ) is Attracting Investor Attention: Here is What You Should Know
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down
HOLX posts better-than-expected Q3 results, but margin contraction and regional headwinds pressure investor sentiment.
Hologic ( HOLX ) Q3 Revenue Beats 1%
Hologic ( NASDAQ:HOLX ) , a global medical technology company specializing in diagnostics and women's health, reported financial results for the third quarter of fiscal 2025 on July 30, 2025. The most notable headline: both GAAP revenue and non-GAAP earnings per share came in ahead of ...
Hologic ( HOLX ) Q3 Earnings and Revenues Beat Estimates
Hologic (HOLX) delivered earnings and revenue surprises of +2.86% and +1.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Hologic Focuses on Breast Health Turnaround This Year: Can It Deliver?
HOLX eyes a Breast Health rebound in Q4, backed by leadership changes, new strategy and Endomag momentum.
Seeking Clues to Hologic ( HOLX ) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Hologic (HOLX) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
HOLX vs. EXAS: Which Cancer Diagnostics Stock Should You Retain Now?
EXAS gains edge over HOLX as rising Cologuard adoption, new launches and bullish EPS trends boost investor appeal.
Hologic's International Momentum Takes Shape: Will Execution Pay Off?
HOLX is leaning into international growth with Surgical division strength and untapped demand driving momentum abroad.
Hologic ( HOLX ) Laps the Stock Market: Here's Why
In the closing of the recent trading day, Hologic (HOLX) stood at $65.37, denoting a +2.64% move from the preceding trading day.
Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report?
HOLX heads into Q3 earnings with revenue and EPS estimates down, tariff pressures mounting, and stock lagging peers.
